Found: 18
Select item for more details and to access through your institution.
Management of alcohol‐related liver disease: the French Association for the Study of the Liver and the French Alcohol Society clinical guidelines.
- Published in:
- Liver International, 2022, v. 42, n. 6, p. 1330, doi. 10.1111/liv.15221
- By:
- Publication type:
- Article
Intrahepatic immune changes after hepatitis c virus eradication by direct‐acting antiviral therapy.
- Published in:
- Liver International, 2020, v. 40, n. 1, p. 74, doi. 10.1111/liv.14226
- By:
- Publication type:
- Article
Non‐virological factors are drivers of hepatocellular carcinoma in virosuppressed hepatitis B cirrhosis: Results of ANRS CO12 CirVir cohort.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 3, p. 384, doi. 10.1111/jvh.13029
- By:
- Publication type:
- Article
Liver Resection for Solitary Transplantable Hepatocellular Carcinoma: The Role of AFP-Score.
- Published in:
- World Journal of Surgery, 2019, v. 43, n. 1, p. 221, doi. 10.1007/s00268-018-4769-5
- By:
- Publication type:
- Article
Correction to: Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful?
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful?
- Published in:
- Abdominal Radiology, 2018, v. 43, n. 7, p. 1670, doi. 10.1007/s00261-017-1377-z
- By:
- Publication type:
- Article
Sorafenib vs surgical resection for hepatocellular carcinoma with macrovascular invasion: A propensity score analysis.
- Published in:
- Liver International, 2017, v. 37, n. 12, p. 1869, doi. 10.1111/liv.13491
- By:
- Publication type:
- Article
Sofosbuvir-Daclatasvir-Simeprevir Plus Ribavirin in Direct-Acting Antiviral-Experienced Patients With Hepatitis C.
- Published in:
- Clinical Infectious Diseases, 2017, v. 64, n. 11, p. 1615, doi. 10.1093/cid/cix214
- By:
- Publication type:
- Article
Impact of hepatobiliary phase liver MRI versus Contrast-Enhanced Ultrasound after an inconclusive extracellular gadolinium-based contrast-enhanced MRI for the diagnosis of benign hepatocellular tumors.
- Published in:
- Abdominal Radiology, 2017, v. 42, n. 3, p. 825, doi. 10.1007/s00261-016-0921-6
- By:
- Publication type:
- Article
Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Autophagy: A Multifaceted Partner in Liver Fibrosis.
- Published in:
- BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/869390
- By:
- Publication type:
- Article
Impact of tumour differentiation to select patients before liver transplantation for hepatocellular carcinoma.
- Published in:
- Liver International, 2011, v. 31, n. 6, p. 794, doi. 10.1111/j.1478-3231.2010.02425.x
- By:
- Publication type:
- Article
Cannabinoid CB2 Receptor Potentiates Obesity- Associated Inflammation, Insulin Resistance and Hepatic Steatosis.
- Published in:
- PLoS ONE, 2009, v. 4, n. 6, p. 1, doi. 10.1371/journal.pone.0005844
- By:
- Publication type:
- Article
The sphingosine 1-phosphate receptor S1P<sub>2</sub> triggers hepatic wound healing.
- Published in:
- FASEB Journal, 2007, v. 21, n. 9, p. 2005, doi. 10.1096/fj.06-6889com
- By:
- Publication type:
- Article
CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis.
- Published in:
- Nature Medicine, 2006, v. 12, n. 6, p. 671, doi. 10.1038/nm1421
- By:
- Publication type:
- Article
Hepatic Stellate Cells and Intrahepatic Modulation of Portal Pressure.
- Published in:
- Digestion, 1998, v. 59, n. 4, p. 416, doi. 10.1159/000007501
- By:
- Publication type:
- Article
Significance of anti-hepatitis C virus core IgM antibodies in patients with chronic hepatitis C.
- Published in:
- Journal of Medical Virology, 1995, v. 47, n. 3, p. 285, doi. 10.1002/jmv.1890470316
- By:
- Publication type:
- Article
A glucagon fragment is responsible for the inhibition of the liver Ca<sup>2+</sup> pump by glucagon.
- Published in:
- Nature, 1987, v. 325, n. 6105, p. 620, doi. 10.1038/325620a0
- By:
- Publication type:
- Article